Proof-of-concept trial on tasquinimod in MPN fibrosis will be conducted as a HOVON trial

I could not be more excited that the proof-of-concept trial on tasquinimod in #MPN #fibrosis based on our findings @GleitzHelene @vanvanka123 @brummendorf and many other will be conducted as a HOVON trial and supported by @oncodeinstitute. Read more below ???????? https://t.co/rOD6vHLdE3

— Rebekka Schneider (@rschneiderlab) August 2, 2023